The Valley Desk

Clinical trial reportScience translational medicinePublished

Extended in vivo activity of VRC01 HIV-1 prophylaxis entails initial protective efficacy and subsequent breakthrough infections

12 of 50 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Science translational medicine
Published
Subject terms
Humans; HIV-1; HIV Infections; Antibodies, Monoclonal; HIV Antibodies; Treatment Outcome; Female; Male; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Breakthrough Infections
PubMed ID
42981432
PubMed Central ID
PMC13739237
Added to directory
Source checked

Report a correction or request removal